Drug Free Solution, Inc.
DSOL
$0.00
-$0.09-98.76%
OTC PK
| 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | 02/28/2013 | |
|---|---|---|---|---|---|
| Net Income | -212.54% | -249.86% | 80.20% | -284.93% | 123.97% |
| Total Depreciation and Amortization | 288.89% | 650.00% | 0.00% | -233.33% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -31.71% | -- | -- | -- | -- |
| Cash from Operations | -179.89% | -62.54% | 82.38% | -257.35% | 128.77% |
| Capital Expenditure | 100.00% | -- | -- | 269.39% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | 269.39% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 229.69% | -84.20% | 194.72% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 225.72% | 209.62% | -84.20% | 194.72% | -120.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.42% | 74.42% | 42.34% | -262.99% | 251.60% |